This result was supported by a study that aimed to analyze the expression of EGFL17 (epithelial growth factor like multiple 7) in GBM using immunohistochemistry and in silico methods, which also showed that high EGFR expression was associated with poor overall survival in GBM patients, emphasizing its potential as a prognostic indicator [16,17]. This evidence concerns the gene EGFR and glioblastoma.